In a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such...
Read MoreTreatment(s) already received-Bone marrow transplant Posts on Medivizor
Does stem cell transplantation affect the quality of life of older patients with NHL?
In a nutshell This study evaluated the quality of life reported by elderly patients with non-Hodgkin's lymphoma (NHL) after a stem cell transplant (SCT). The authors concluded that quality of life for these patients was very good following SCT. Some background Autologous SCT is the standard of care in first-line treatment for...
Read MoreUsing alpha-interferon to treat residual chronic myeloid leukemia after transplantation
In a nutshell This study looked at the effectiveness of interferon-alpha (IntronA) treatment in patients with chronic myeloid leukemia (CML) with residual disease after transplantation. Researchers found that this treatment may be useful in patients with signs of disease after transplant. Some background Chronic myeloid leukemia is a cancer...
Read MoreSearching for participants with leukemia and lymphoma to try a new treatment before stem cell transplantation
In a nutshell This study will investigate the effects of high-pressure oxygen on the transplant of umbilical cord blood stem cells in patients with blood cancers. The main outcome that will be measured is the time it takes for white blood cells to recover after treatment. This trial is recruiting in New York, US. The details Stem cell transplant (SCT)...
Read MoreEvaluating ixazomib maintenance therapy for patients with multiple myeloma
In a nutshell This study evaluated the safety and effectiveness of ixazomib (Ninlaro) given after a stem cell transplant for patients with multiple myeloma (MM). This study concluded that ixazomib maintenance therapy is effective for these patients, with manageable side effects. Some background Multiple myeloma is a type of cancer of the bone marrow...
Read MoreSearching for patients to try a combination treatment for multiple myeloma.
In a nutshell The study will investigate the effects of carfilzomib (Kyprolis), pomalidomide (Pomalyst), and dexamethasone (Decadron) in multiple myeloma (MM). The main outcome that will be measured will be the percentage of patients who have no signs or symptoms of MM after treatment (completed response). This study is recruiting in Georgia, Unites...
Read MoreBortezomib plus lenalidomide for patients with multiple myeloma a after stem cell transplant
In a nutshell This study evaluated the safety and effectiveness of bortezomib (Velcade) and lenalidomide (Revlimid) for patients with multiple myeloma after stem cell transplantation. This study found this combination is effective for these patients, with few side effects. Some background Multiple myeloma (MM) is a type of cancer...
Read MoreMinimal residual disease and its association with transplant success in Multiple Myeloma.
In a nutshell This study monitored the development of minimal residual disease (MRD) after transplant for multiple myeloma (MM). The main finding was that different patterns of MRD development are associated with varying success after stem cell transplant for MM. Some background There are many treatments for MM. Patients are often cured fully by...
Read MoreKidney problems in Multiple Myeloma: do they affect the success of stem cell transplant?
In a nutshell This study investigated the effect of kidney problems on the success of stem-cell transplant for Multiple Myeloma (MM). The main finding was that the stage of the kidney problems did not impact the effects of stem-cell transplant. Some background Stem-cell transplant involves the transfer of cells to a patient. It is commonly used in the...
Read MoreEvaluating the impact of early PET/CT scanning on survival in patients with lymphoma after stem cell transplant
In a nutshell This study evaluated the impact of early FDG PET/CT scanning on the survival of patients with lymphoma after allogeneic stem cell transplantation (alloSCT). This study concluded that having positive scan results at 3 months after alloSCT may highly predict relapse and poor survival in these patients. Some background An alloSCT is a...
Read MoreEvaluating the impact of early PET/CT scanning on survival in patients with lymphoma after stem cell transplant
In a nutshell This study evaluated the impact of early FDG PET/CT scanning on the survival of patients with lymphoma after allogeneic stem cell transplantation (alloSCT). This study concluded that having positive scan results at 3 months after alloSCT may highly predict relapse and poor survival in these patients. Some background An alloSCT is a...
Read MoreEvaluating brentuximab vedotin after alloSCT in patients with recurrent Hodgkin Lymphoma
In a nutshell This study evaluated the outcomes of brentuximab vedotin (Adcetris) treatment for patients with relapsed (recurrent) or progressive (tumor grows or spreads) Hodgkin’s lymphoma (HL) after allogeneic (allo) stem cell transplantation (SCT). This study concluded that brentuximab vedotin is safe and effective for these patients. Some...
Read More
